1h Free Analyst Time
The controlled substance market in the US is forecasted to grow by USD 15.56 billion during 2025-2030, accelerating at a CAGR of 6.6% during the forecast period. The report on the controlled substance market in the US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of chronic diseases and an aging population, increasing diagnosis and awareness of neurological and psychiatric disorders, pharmaceutical innovation in advanced delivery systems.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The controlled substance market in the US is segmented as below:
By Product Type
- Opioids
- Stimulants
- Depressants
- Cannabinoids drugs
By Indication
- Pain management
- Sleep disorder
- Seizure
- Others
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
By Region
- North America
- US
The report on the controlled substance market in the US covers the following areas:
- Controlled substance market in the US sizing
- Controlled substance market in the US forecast
- Controlled substance market in the US industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Product Type
9 Market Segmentation by Indication
10 Market Segmentation by Distribution Channel
11 Customer Landscape
12 Drivers, Challenges, and Opportunity
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global controlled substance market in us: AbbVie Inc., Amneal Pharmaceuticals Inc., Ampac Fine Chemicals, Aurobindo Pharma Ltd., Benuvia Operations LLC, Cambrex Corp., Chattem Chemicals Inc., Curia Global Inc., Hikma Pharmaceuticals Plc, Lannett Co Inc., Merck and Co. Inc., Noramco Inc., Pfizer Inc., Purisys LLC, Rhodes Pharmaceuticals L.P., Siegfried Holding AG, SpecGx LLC, Teva Pharmaceutical Ltd., Zealand Pharma.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing emphasis on abuse deterrent formulations."
According to the report, one of the major drivers for this market is the high prevalence of chronic diseases and an aging population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amneal Pharmaceuticals Inc.
- Ampac Fine Chemicals
- Aurobindo Pharma Ltd.
- Benuvia Operations LLC
- Cambrex Corp.
- Chattem Chemicals Inc.
- Curia Global Inc.
- Hikma Pharmaceuticals Plc
- Lannett Co Inc.
- Merck and Co. Inc.
- Noramco Inc.
- Pfizer Inc.
- Purisys LLC
- Rhodes Pharmaceuticals L.P.
- Siegfried Holding AG
- SpecGx LLC
- Teva Pharmaceutical Ltd.
- Zealand Pharma
